MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Diffusion MRI tractometry findings in Dystonia- A UK Biobank study

    C. Maciver, M. Wadon, G. Bailey, A. Schalkamp, C. Sandor, D. Jones, C. Tax, K. Peall (Cardiff, United Kingdom)

    Objective: To compare key white matter motor pathways between those diagnosed with dystonia and unaffected controls, using data collected by the UK Biobank, processed and…
  • 2022 International Congress

    Association of a new pathogenic variant of LRRK2 with modifying lysosomal genes in a family with Parkinson’s disease

    L. Vela-Desojo, M. Osuna-Lopez, C. Guerrero, A. Pascual, F. Palau, J. Hoenicka (Alcorcón, Spain)

    Objective: To characterize a Parkinson’s disease (PD) family with high recurrence of the disease. Background: Parkinson’s disease (PD) is a complex neurodegenerative disorder in which…
  • 2022 International Congress

    Movement disorder practice in a rural setting: challenges and opportunities and utility of telemedicine

    P. Karau, R. Mbijiwe (Meru, Kenya)

    Objective: To describe the experience of a movement disorder practice in a rural setting, the role of telehealth and the conditions diagnosed and managed Background:…
  • 2022 International Congress

    Malignant catatonia secondary to clozapine withdrawal: A case report

    T. Thammongkolchai, P. Termsarasab (Bangkok, Thailand)

    Objective: To report a patient with malignant catatonia from abrupt clozapine discontinuation. Background: Clozapine blocks 5HT2A/5HT2C serotonin and dopamine receptors. Cholinergic and serotoninergic rebounds have…
  • 2022 International Congress

    Dried blood and plasma spots for the measurement of neurofilament light chain and inflammatory cytokines in patients with REM sleep behaviour disorder

    B. Huxford, C. Simonet, L. Carbonell, A. Zirra, N. Vickaryous, A. Gill, A. Schrag, R. Dobson, A. Noyce (London, United Kingdom)

    Objective: The objective of this study was to investigate the relationship between plasma and dried blood/ plasma spot measurements of inflammatory markers (IFN-ɣ, IL-1β, IL-6,…
  • 2022 International Congress

    Choice of shoulder muscles for the multi-pattern treatment of upper limb spasticity with botulinum neurotoxin injections

    J. Jacinto (Alcabideche, Portugal)

    Objective: To present an experts’ consensus on the use of botulinum neurotoxin (BoNT) injections in the multi-pattern treatment of shoulder spasticity to increase awareness of…
  • 2022 International Congress

    Serum Metabolomic Characterization of PLA2G6-associated Dystonia-Parkinsonism: a case-control biomarker study

    C. Chen, M. Lou, Y. Sun, W. Wang, J. Wang (Shanghai, China)

    Objective: PLA2G6 is the causative gene for autosomal recessive Dystonia-Parkinsonism (PARK14). This case-control biomarker study aimed to test serum metabolomics of patients diagnosed as PARK14.…
  • 2022 International Congress

    Performance of oral diadochokinesis in Parkinson’s Disease motor subtypes

    V. Dos Santos, R. Rothe-Neves,, A. Bressanelli, I. Klein, M. Olchik (Porto Alegre, Brazil)

    Objective: To compare the performance of the oral diadochokinesis task in the different motor subtypes of PD (postural instability/gait difficulty - PIGD, tremor-dominant - TD,…
  • 2022 International Congress

    Cannabis treatment in patients with Huntington’s disease in a clinic cohort was safe and effective

    N. Omer, A. Bar David, N. Geva, Y. Zlotnik, T. Gurevich, S. Essa (Tel-Aviv, Israel)

    Objective: To estimate the safety and efficacy of Cannabis treatment in HD patients. Background: Huntington's disease (HD) is a neurodegenerative progressive disorder inherited in an…
  • 2022 International Congress

    MPTP-induced structural reorganization of neurons in mice Basal Ganglia: Verifying the sequelae of differential toxicity

    B. Bhaduri, I. Datta, R. Yadav, D. Srinivas, P. Alladi (Bangalore, India)

    Objective: To evaluate the changes in the neuronal arborization of the medium spiny neurons of striatum & substantia nigra neurons,  in response to MPTP in…
  • « Previous Page
  • 1
  • …
  • 660
  • 661
  • 662
  • 663
  • 664
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley